###begin article-title 0
###xml 46 68 46 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 46 67 <span type="species:ncbi:1496">Clostridium difficile</span>
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 60 81 <span type="species:ncbi:1496">Clostridium difficile</span>
A genome comparison of non-epidemic and epidemic strains of Clostridium difficile reveals gene gains that could explain how a hypervirulent strain has emerged
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 316 329 316 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 22 43 <span type="species:ncbi:1496">Clostridium difficile</span>
###xml 316 328 <span type="species:ncbi:1496">C. difficile</span>
The continued rise of Clostridium difficile infections worldwide has been accompanied by the rapid emergence of a highly virulent clone designated PCR-ribotype 027. To understand more about the evolution of this virulent clone, we made a three-way genomic and phenotypic comparison of an 'historic' non-epidemic 027 C. difficile (CD196), a recent epidemic and hypervirulent 027 (R20291) and a previously sequenced PCR-ribotype 012 strain (630).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
Although the genomes are highly conserved, the 027 genomes have 234 additional genes compared to 630, which may contribute to the distinct phenotypic differences we observe between these strains relating to motility, antibiotic resistance and toxicity. The epidemic 027 strain has five unique genetic regions, absent from both the non-epidemic 027 and strain 630, which include a novel phage island, a two component regulatory system and transcriptional regulators.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
A comparison of a series of 027 isolates showed that some of these genes appeared to have been gained by 027 strains over the past two decades. This study provides genetic markers for the identification of 027 strains and offers a unique opportunity to explain the recent emergence of a hypervirulent bacterium.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 126 139 126 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 279 292 279 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 352 365 352 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 658 671 658 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
###xml 126 138 <span type="species:ncbi:1496">C. difficile</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 279 291 <span type="species:ncbi:1496">C. difficile</span>
###xml 352 364 <span type="species:ncbi:1496">C. difficile</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
###xml 658 670 <span type="species:ncbi:1496">C. difficile</span>
###xml 898 906 <span type="species:ncbi:9606">patients</span>
###xml 1240 1248 <span type="species:ncbi:9606">patients</span>
Clostridium difficile, a spore-forming anaerobic bacillus that often resides in the gut of mammals, is the causative agent of C. difficile infection (CDI) (reviewed in [1]). The hospital environment and patients undergoing antibiotic treatment provide a discrete ecosystem where C. difficile persists and selected virulent clones thrive. Consequently, C. difficile is the most frequent cause of nosocomial diarrhea worldwide, where patients exhibit a range of symptoms from mild diarrhea to life threatening pseudomembranous colitis (PMC) [2,3]. In most cases of CDI antibiotic therapies disrupt the protective gut microbiota, whereupon ingested or existent C. difficile spores germinate, colonize the gastrointestinal tract and produce toxins. Another feature of CDI is the high relapse rate due to re-infection or reactivation of infection [2,3]. The population at risk for CDI includes not only patients on antimicrobial and other therapies that can alter the balance of the gut microbiota (for example, antacid/proton pump inhibitors and non-steroidal anti-inflammatory drugs), but also the immunocompromised and the elderly. Given the continued use of broad-spectrum antibiotics and the rising numbers of immunocompromised and elderly patients, the problems associated with CDI are unlikely to recede.
###end p 10
###begin p 11
###xml 63 76 63 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 934 947 934 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 63 75 <span type="species:ncbi:1496">C. difficile</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 916 924 <span type="species:ncbi:9606">patients</span>
###xml 934 946 <span type="species:ncbi:1496">C. difficile</span>
Alarmingly, in the past 5 years a new group of highly virulent C. difficile strains has emerged to cause outbreaks of increased disease severity in North America and Europe. Several studies have shown that patients infected with these PCR-ribotype 027 strains have more severe diarrhea, higher mortality and more recurrences [4-8]. Prior to 2003, only a handful of these strains were isolated in the UK, whereas currently most typed isolates are PCR-ribotype 027. This is also mirrored in Canada, where 027 strains were undetected in 2000, but reached 75.2% of all PCR-ribotyped strains by 2003 [9]. The emergence of 027 strains might partially explain the 72% annual increase in mortality in the UK due to CDI to 6,500 cases in 2006 [7]. The CDI outbreaks at the Stoke Mandeville hospital, Buckinghamshire, marked the arrival of the epidemic 027 isolates to the UK. Between April 2003 and March 2006 a total of 498 patients acquired C. difficile at the hospital (measured by onset of symptoms 72 hours after admission), of which 127 died [10].
###end p 11
###begin p 12
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 544 551 <span type="species:ncbi:9606">patient</span>
###xml 691 698 <span type="species:ncbi:9606">patient</span>
PCR-ribotype 027 strains are genetically highly uniform, which is confirmed by the application of diverse genotyping methods. For example, 027 strains are invariably designated as BI by restriction endonuclease analysis, NAP1 (North American pulsotype 1) by pulse field gel electrophoresis, are exclusively toxinotype III by toxinotyping and are indistinguishable by multi-locus sequence analysis [11]. The earliest retrospective recorded PCR-ribotype 027 isolate was strain CD196 in 1985, which is a non-epidemic strain isolated from a single patient with CDI in a Paris hospital [12]. The next retrospective recorded 027 isolate was a non-epidemic strain designated BI-1, which was from a patient with CDI in a Minneapolis hospital in 1988 [13]. Since 1988 a further 19 BI designated strains (all PCR-ribotype 027) have been isolated and characterized by Gerding and colleagues representing a useful time-line of the evolution of 027 strains (DN Gerding, personal communication).
###end p 12
###begin p 13
###xml 177 190 177 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 177 189 <span type="species:ncbi:1496">C. difficile</span>
Comparative phylogenomics (whole genome comparisons of bacteria using DNA microarrays combined with Bayesian-based algorithms to model the phylogeny) was recently applied to 75 C. difficile strains of diverse origin, including 19 strains confirmed as PCR-ribotype 027 (16 BI strains from the US, CD196, a strain from a recent Canadian outbreak and a representative strain from the Stoke Mandeville outbreak designated R20291). All 027 strains formed a tight clade, which was distinct from the other 56 strains analyzed [14]. Closer inspection of the 027 clade revealed micro-evolution among strains with the historic non-epidemic CD196 and BI-1 strains as progenitors compared to their recently isolated counterparts [14]. These studies confirm the clonal nature of PCR-ribotype 027 strains and that they are continuing to evolve.
###end p 13
###begin p 14
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 247 259 247 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile</italic>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 475 488 475 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdR</italic>
###xml 695 699 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdC</italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 870 879 870 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdC</italic>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1139 1143 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdC</italic>
###xml 1389 1394 1389 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdC </italic>
###xml 1433 1435 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2109 2111 2109 2111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 12 <span type="species:ncbi:1496">C. difficile</span>
###xml 247 259 <span type="species:ncbi:1496">C. difficile</span>
###xml 475 487 <span type="species:ncbi:1496">C. difficile</span>
C. difficile is known to produce two related glucosylating toxins, named toxin A and toxin B, which are encoded on the pathogenicity locus (PaLoc) [15]. For some time, toxin production has been the main focus of study when addressing virulence of C. difficile. However, in the hamster model of infection toxin B plays the most significant role in infection [16]. A recent report has shown the binding domain of toxin B in 027 strains to be highly divergent compared to other C. difficile strains [8]. However, the significance of the difference of the 027 toxin B gene sequence has yet to be investigated. The PaLoc also includes toxin regulatory components, including tcdR, a sigma factor, and tcdC, a negative regulator that destabilizes the TcdR-holoenzyme to prevent transcription of the PaLoc [17]. It has been reported that some 027 strains can produce more toxin in vitro [18], which was initially attributed to deletions in the negative regulator tcdC. Further characterization has revealed that the 18-bp in-frame deletion was found to have no effect on toxin production [19]. Two additional deletions have been identified within tcdC, a 39 and single base-pair deletion. The single base-pair deletion results in the formation of a stop codon downstream and truncation of the protein, thus leading to increased toxin production. However, various deletions have been identified in tcdC in non-epidemic PCR-ribotypes as well [20], suggesting the increased virulence cannot solely be attributed to these deletions. This has stimulated debate on the mode of hypervirulence in the epidemic 027 strains. Apart from classic virulence determinants such as toxin production, other factors such as antibiotic resistance, increased motility and adherence in the gut, increased resistance to bile salts and increased transmissibility manifested through sporulation might explain the emergence of epidemic 027 strains. A recent report comparing three 'historical' 027 strains from Sweden with an epidemic strain concluded that the epidemic strain sporulated more readily than its three non-epidemic counterparts [21].
###end p 14
###begin p 15
###xml 98 110 98 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile</italic>
###xml 178 191 178 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 98 110 <span type="species:ncbi:1496">C. difficile</span>
###xml 178 190 <span type="species:ncbi:1496">C. difficile</span>
###xml 289 296 <span type="species:ncbi:9606">patient</span>
Given the medical and economic importance of CDI and the difficulties in studying the genetics of C. difficile, we recently reported the complete genome sequence of a pathogenic C. difficile strain [22]. The strain chosen, 630 (PCR-ribotype 012), was a multi-drug-resistant isolate from a patient with PMC at a hospital in Zurich in 1982 [22]. The full sequence revealed a 4.29 Mb chromosome with a mosaic of potential mobile genetic elements, antibiotic resistance genes and virulence determinants [22].
###end p 15
###begin p 16
###xml 41 54 41 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 261 274 261 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 41 53 <span type="species:ncbi:1496">C. difficile</span>
###xml 261 273 <span type="species:ncbi:1496">C. difficile</span>
The rapid international emergence of the C. difficile 027 strain lineage provides a unique opportunity to understand the recent emergence of a highly virulent bacterium. In this study we undertake a three-way genome comparison of an 'historic' non-epidemic 027 C. difficile strain (CD196), a recent epidemic and hypervirulent 027 strain (R20291) and the previously published PCR-ribotype 012 strain (630). Where possible we relate genetic differences to phenotypic differences observed in these strains with respect to motility, survival, antibiotic resistance and toxicity.
###end p 16
###begin title 17
Results and discussion
###end title 17
###begin title 18
Genome comparison of the PCR-ribotype 027 strains (CD196 and R20291) and strain 630
###end title 18
###begin p 19
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The two newly sequenced genomes of the PCR-ribotype 027 strains (CD196 historic and R20291 modern; Table 1) were compared with the previously sequenced strain 630 (PCR-ribotype 012). The three strains share 3,247 core genes, including those encoding determinants important for pathogenesis, such as antimicrobial resistance, ethanolamine/propanediol metabolism, sporulation, a beta-lactamase-inducing penicillin-binding protein, a quaternary ammonium compound-resistance protein, tellurium resistance proteins, a putative nogalamycin resistance protein and L-rhamnose biosynthesis (Figure 1). There are 505 coding sequences (CDSs) unique to 630 compared to the 027 strains, whereas there are 47 CDSs unique to R20291 and three CDSs unique to CD196 (Figure 1). The locations of regions of genetic difference between the three strains are highlighted in the concentric circular chromosome representations of the three genomes (Figure 2). There are 234 genes unique to both 027 ribotypes spread among at least 50 regions of genetic difference (Figure 2; Additional data file 1). These include a phage island, transposon genes, two-component response regulators, drug resistance genes, transporter genes and type I restriction enzyme/restriction modification genes (Additional data file 1).
###end p 19
###begin p 20
Strains used in this study
###end p 20
###begin p 21
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of orthologues CDSs in <italic>C. difficile </italic>strains 630, CD196 and R20291</bold>
###xml 36 48 <span type="species:ncbi:1496">C. difficile</span>
Distribution of orthologues CDSs in C. difficile strains 630, CD196 and R20291. The Venn diagram shows the number of genes unique, shared or core between the three strains. The associated pie charts show the breakdown of the functional categories assigned to these CDS.
###end p 21
###begin p 22
###xml 28 41 28 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Circular representations of <italic>C. difficile </italic>chromosomes</bold>
###xml 28 40 <span type="species:ncbi:1496">C. difficile</span>
Circular representations of C. difficile chromosomes. From the outside (scale in bp): circles 1 and 2 show the position of R20291 CDS transcribed in a clockwise and anti-clockwise direction colored according to predicted function; circle 3 shows CDS unique to R20291; circle 4 shows CDS unique to both R20291 and CD196; circle 5 shows GC content; circle 6 shows GC deviation (> 0%, olive; < 0%, purple). Color coding for CDS functions: dark blue, pathogenicity/adaptation; black, energy metabolism; red, information transfer; dark green, surface-associated; cyan, degradation of large molecules; magenta, degradation of small molecules; yellow, central/intermediary metabolism; pale green, unknown; pale blue, regulators; orange, conserved hypothetical; brown, pseudogenes; pink, phage and IS (Insertion Sequence) elements; grey, miscellaneous.
###end p 22
###begin p 23
###xml 355 368 355 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 355 371 <span type="species:ncbi:272563">C. difficile 630</span>
There are 14 CDSs that have been disrupted by an insertion in both 027 strains but are intact in 630; conversely, 12 CDSs are intact in both 027 strains but have been disrupted in 630 (Additional data file 2). All three genomes have multiple copies of genes for transposase-like proteins that have been inserted both intragenically and intergenically. In C. difficile 630 there are eight full transposon copies and two remnant copies; all eight functional copies have inserted within CDSs. In both 027 strains there are 17 transposon copies, of which only 6 inserted within CDSs. Only three CDSs are interrupted by transposons in all three strains. Furthermore, three CDSs have been truncated by sequence loss in both 027 strains but are intact in 630 and 10 CDSs are truncated in 630 but not 027 strains (Additional data file 2). Finally, point mutations have resulted in frameshifts exclusively in three 630 CDSs and 10 of the 027 strain CDSs (Additional data file 2).
###end p 23
###begin title 24
Toxin-related genes specific to 027
###end title 24
###begin p 25
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 102 115 102 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdB </italic>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 624 629 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdB </italic>
###xml 722 731 722 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1061 1062 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 102 114 <span type="species:ncbi:1496">C. difficile</span>
Variation within the PaLoc region (containing toxins A and B and their associates genes) [15] between C. difficile strains has been observed frequently and has been used to develop the toxinotyping method to distinguish strains [23-25]. PCR-ribotype 027 isolates are invariably toxinotype III, whereas 630 (PCR-ribotype 012) is toxinotype 0. A comparison of the PaLoc sequences from 630, R20291 and CD196 confirms the previous data, indicating that the tcdB sequence varies among strains, particularly at the 3' region, which encodes the toxin-binding domain [26]. However, there is a high level of sequence conservation in tcdB between the 027 strains CD196 and R20291 compared to strain 630. Examination of the relative in vitro cytotoxicity of these three strains on several cell lines confirms differences in both toxicity and cell line specificity (Table 2). Purified toxin B from R20291 has more potent activity than that from 630 in all eight cell lines tested whereas the historic 027 (CD196) is more potent in six of the eight cell lines tested (Table 2). Given the recent demonstration in the hamster model of CDI that toxin B, and not toxin A, is essential for virulence, the observation that toxin B from strain R20291 has a more potent activity over a broader range of cell types may indicate that this is a contributory factor to the hypervirulence of R20291 [16].
###end p 25
###begin p 26
Toxin B cytotoxicity assay
###end p 26
###begin p 27
Cytotoxicity as expressed as toxin molarity (M) that induces 50% cell rounding after 24 hour exposure.
###end p 27
###begin p 28
###xml 78 90 78 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tcdC </italic>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 78 90 <span type="species:ncbi:1496">C. difficile</span>
Regulation of toxin expression has also been shown to vary between strains of C. difficile, which has been attributed to mutations in the negative regulator tcdC [9]. The most notable of these mutations is the 1-bp deletion present in 027 strains that results in a frame shift and truncation of TcdC, causing de-repression of the PaLoc [17]. A single base deletion at position 117, resulting in truncation of TcdC at the 66th amino acid, was confirmed in both R20291 and CD196 but absent from 630. The presence of the 18-bp deletions in both R20291 and CD196 but their absence from 630 was confirmed.
###end p 28
###begin p 29
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtA </italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtB</italic>
###xml 188 201 188 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtA </italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtB </italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtR </italic>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 738 751 738 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdtR </italic>
###xml 188 200 <span type="species:ncbi:1496">C. difficile</span>
###xml 738 754 <span type="species:ncbi:272563">C. difficile 630</span>
The binary ADP-ribosyltransferase toxin, first identified in 1988 in the strain CD196 [12], consists of two genes, cdtA and cdtB. Surveys have identified the binary toxin in up to 8.6% of C. difficile strains [27-30]; recently, however, binary toxin positive PCR-ribotype 027 incidence has reached 41.3% in the UK [31]. Additionally, the binary toxin has been linked with increased severity of disease [32-34]. Sequence analysis confirms the presence of full-length cdtA and cdtB genes in both CD196 and R20291, which by contrast have accumulated sequence deletions, several frameshift mutations and in-frame stop codons in 630. Recently, the CDS upstream has been identified as the binary toxin response regulator, designated cdtR [35]. C. difficile 630 contains a functional copy of cdtR despite lacking binary toxin, and CdtR is 96% identical to the homologues found in both 027 isolates.
###end p 29
###begin title 30
Differences in antibiotic resistance between 630 and PCR-ribotype 027 strains
###end title 30
###begin p 31
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gyrA </italic>
###xml 235 248 235 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 534 539 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gyrB </italic>
###xml 235 251 <span type="species:ncbi:272563">C. difficile 630</span>
In contrast to strain 630, the epidemic 027 strains are highly resistant to fluoroquinolones due to point mutations in the DNA gyrase genes [36]. Comparison of the gyrA gene identified seven point mutations in DNA gyrase genes between C. difficile 630 and both 027 strains. Four mutations are silent and two substitutions - Leu406Ile and Asp468Asn - conserved. Interestingly, the previously described Thr82Ile conversion was only present in the epidemic 027 [36]. Two silent point mutations (A1458G and C1890T) were identified in the gyrB gene of the 027 strains. Three fluoroquinolones (gatifloxacin, moxifloxacin and lexofloxacin) were used and results showed that R20291 was highly resistant to the fluoroquinolones (</= 32 mg/l for all three fluoroquinolones), but CD196 was fluoroquinolone sensitive (gatifloxacin minimum inhibitory concentration (MIC) 1.5 mg/l, moxifloxacin MIC 2 mg/l and lexofloxacin MIC 3 mg/l) and 630 was sensitive or had intermediate resistance to fluoroquinolones (gatifloxacin MIC 2 mg/l, moxifloxacin MIC 1.5 mg/l and lexofloxacin 6 mg/l).
###end p 31
###begin p 32
###xml 97 110 97 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">027</italic>
###xml 340 342 340 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 97 113 <span type="species:ncbi:272563">C. difficile 630</span>
Sequence data revealed that both 027s have acquired two unique conjugative transposons absent in C. difficile 630. One of these transposons (CTn-027) encodes a novel chloramphenicol resistance gene (CDR20291_3461). R20291 and CD196 demonstrated intermediate resistance (MIC 16 mg/l), but 630 was sensitive to chloramphenicol (MIC 12 mg/l) (P < 0.05).
###end p 32
###begin p 33
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ermB1</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ermB2</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5398 </italic>
###xml 230 243 230 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 422 426 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tetM</italic>
###xml 442 443 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 446 451 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5397 </italic>
###xml 502 515 500 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 682 684 680 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 12 <span type="species:ncbi:1496">C. difficile</span>
###xml 230 246 <span type="species:ncbi:272563">C. difficile 630</span>
###xml 502 518 <span type="species:ncbi:272563">C. difficile 630</span>
C. difficile strain 630 has two copies of the erythromycin resistance gene (ermB1/CD2007 and ermB2/CD2010) on a mobile transposon Tn5398 (CD2001-2010b), which was absent in CD196 and R20291. However, experimental data showed that C. difficile 630 and R20291 were erythromycin resistant (MIC >/= 256 mg/l) whereas CD196 had intermediate resistance (MIC 2 mg/l). Additionally, strain 630 has a tetracycline resistance gene (tetM; CD0508) on CTn3/Tn5397 (CD0496-511), which is absent in CD196 and R20291. C. difficile 630 demonstrated tetracycline resistance (MIC 64 mg/l) in contrast to CD196 and R20291, which were tetracycline sensitive (MIC 0.17 mg/l and 0.22 mg/l, respectively) (P < 0.001).
###end p 33
###begin p 34
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
The difference between drug resistance patterns may reflect changes in antibiotic policy. For example, both CD196 and 630 predate 1992 when Golledge et al. [37] demonstrated clindamycin not to be a risk factor; subsequently, clindamycin use has been strongly associated with PCR-ribotype 027 outbreaks [38-40]. This demonstrates that antibiotic usage may be driving the evolution of drug resistance and the predominance of certain isolates.
###end p 34
###begin title 35
027-specific genes involved in flagella biosynthesis, glycosylation and motility
###end title 35
###begin p 36
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 395 408 395 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 395 407 <span type="species:ncbi:1496">C. difficile</span>
Flagella have been found to be important for motility in several enteric pathogens as a prerequisite to traverse the mucous layer of the gut to interact with gut epithelial cells [41-43]. Additionally, chemotaxis mediated through motility is important in survival, to enable movement towards nutrient-rich sources and movement away from noxious environments. Flagella have been observed in some C. difficile strains [44,45]. Post-translational modification of flagellin proteins by glycosylation has been shown to be prevalent in several bacterial pathogens and the loci encoding these modifications are frequently located adjacent to the structural flagellin genes [46]. Such modifications are important in subverting host immune defenses [47], autoagglutination [48] and adhesion and colonization [49].
###end p 36
###begin p 37
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
In 630, flagella-associated genes are found in two loci, F1 (CD0226-CD0240) and F3 (CD0245-CD0271), which are separated by an inter-flagella locus F2 (CD0241-CD0244). Loci F2 encodes a phosphoserine phosphatase, two conserved hypothetical proteins and a putative CDP-Glycerol:Poly (glycerophosphate) glycerophosphotransferase [14] (Figure 3). Microarray analysis of this region previously showed a loss of, or high divergence in, F1 and F2 in all 027 isolates tested [14]. The sequence data from both R20291 and CD196 show that the F1 locus has been retained, but with only 84 to 90% sequence identity, whereas the four genes present in the inter-flagella F2 locus of 630 have been replaced by six different genes encoding a glycosyl transferase (family 2), two putative uncharacterized proteins, a putative carbamoyl-phosphate-synthetase and a putative ornithine cyclodeaminase (Figure 3).
###end p 37
###begin p 38
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ACT comparison of flagellin and flagellin glycosylation-associated loci</bold>
ACT comparison of flagellin and flagellin glycosylation-associated loci. F1 genes are CD0226-240 (630), CDR20291_0227- 241 (R20291), and CD196_0240-254 (CD196). F2 genes are CD0241-244 (630), CDR20291_0242-247 (R20291), and CD196_0255-260 (CD196). F3 genes are CD0245-271 (630), CDR20291_0248-275 (R20291), and CD196_0261-288 (CD196). Red bars indicate > 84% DNA sequence identity.
###end p 38
###begin p 39
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 218 231 218 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 218 234 <span type="species:ncbi:272563">C. difficile 630</span>
The variation in the F1 region between 630 and the 027 ribotypes may be important in motility, as there are clear phenotypic differences in the motility of 630 and the 027 ribotypes CD196, R20291 and BI-16 (Figure 4). C. difficile 630 is less motile than the 027 ribotypes, whereas M120 is non-motile (Figure 4). Microarray data have shown the absence/divergence of the complete F3 region in M120 [14]. Recent sequence data for M120 have confirmed the deletion of the entire F3 region in this strain [50], explaining the lack of motility for strain M120. The subtle differences in motility between the 630 and the 027 ribotypes may be due to the levels of sequence conservation over the F1 region.
###end p 39
###begin p 40
###xml 32 45 32 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparative motility assays for <italic>C. difficile </italic>strains</bold>
###xml 32 44 <span type="species:ncbi:1496">C. difficile</span>
Comparative motility assays for C. difficile strains. The motility of strain 630 was compared to that of both recent and historic 027 ribotypes, R20291, BI-16 and CD196; M120 was the non-motile control. Strains were inoculated into 0.05% BHI agar and incubated for 24 hours in an anaerobe chamber. The motility is visualized as stalactite projections.
###end p 40
###begin p 41
###xml 247 268 247 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Campylobacter jejuni </italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FlaA</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 546 548 546 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 247 267 <span type="species:ncbi:197">Campylobacter jejuni</span>
The different genes present in the F2 region of 630 and the 027 ribotypes may be important in the glycosylation of the flagella, as the six genes present in R20291 and CD196 contain glycosyl transferases. Studies in other enteric bacteria such as Campylobacter jejuni have shown that both Flagellin, encoded by FlaA, as well as post-translational modifications of it are required for autoagglutination, which is linked to virulence [48]. Significant differences in autoagglutination between 630 and the more recent 027 isolates R20291 and BI-16 (P < 0.05) were observed, whereas the more historic 027 isolates BI-1 and CD196 show no significant difference in autoagglutination compared to 630 (Figure 5). The differences in autoagglutination observed between 630 and the recent 027 isolates are likely to be multifactorial as, in addition to flagella and glycosylation, other surface phenomena can contribute to autoagglutination.
###end p 41
###begin p 42
###xml 21 34 21 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Autoagglutination of <italic>C. difficile </italic>strains</bold>
###xml 43 56 43 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 550 552 548 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 569 570 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 669 671 667 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 21 33 <span type="species:ncbi:1496">C. difficile</span>
###xml 43 55 <span type="species:ncbi:1496">C. difficile</span>
Autoagglutination of C. difficile strains. C. difficile strains were grown on BHI plates for 1 to 2 days, then inoculated into pre-equilibrated phosphate-buffered saline to an OD600 nm of 1.0 (+/- 0.1). These were incubated for 24 hours in pre-equilibrated glass tubes, then the OD600 nm was measured. The percentage of autoagglutination was normalized to the starting OD ((Starting OD - Final OD)/Final OD x 100). The bars indicate the percentage of cells autoagglutinating. Significant differences in autoagglutination are marked with an asterisk; P < 0.05, Students t-test. M120 is a non-motile strain thar autoagglutinates to a significantly higher level than 630 (P < 0.05).
###end p 42
###begin p 43
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 590 605 590 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae</italic>
###xml 607 623 607 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escheichia coli </italic>
###xml 627 646 627 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica</italic>
###xml 727 741 727 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus </italic>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 936 962 936 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 590 605 <span type="species:ncbi:666">Vibrio cholerae</span>
###xml 627 646 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 727 747 <span type="species:ncbi:1309">Streptococcus mutans</span>
###xml 936 962 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Four 027 unique genes upstream of the flagella F1 region (CDR20291_0223-0226 and CD196_0236-0239) that are absent in 630 may be involved in virulence. The four CDSs encode DTDP-4-dehydrorhamnose reductase, glucose-1-phosphate thymidylyltransferase, DTDP-4-dehydrorhamnose 3,5-epimerase and DTDP-glucose 4,6-dehydratase. These four enzymes (RlmA, B, C and D) are involved in the synthesis of L-rhamnose. Carbohydrates such as L-rhamnose can act as structural elements as well as energy sources [51] and can be important virulence factors in both Gram-positive and Gram-negative bacteria. In Vibrio cholerae, Escheichia coli and Salmonella enterica, L-rhamnose is an important residue in the O-antigen of lipopolysaccharides. In Streptococcus mutans, L-rhamnose is part of an antigen involved in colonization of tooth surfaces [52] and mutations in this pathway have been shown to prevent initiation and maintenance of infection [53]. In Mycobacterium tuberculosis, L-rhamnose links peptidoglycan and arabinogalactan to form the unique cell wall. Given their co-location in the F regions, it is possible that these genes may play a role in flagellin glycosylation in the 027 strains.
###end p 43
###begin title 44
027 specific regulatory genes that may be important in survival
###end title 44
###begin p 45
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr </italic>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr2</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrA </italic>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrB </italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrC </italic>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrD </italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr1 </italic>
###xml 442 455 442 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrB </italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrD</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrA</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrC</italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr1 </italic>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr </italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrA </italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agrD</italic>
###xml 787 809 787 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 833 838 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">agr2 </italic>
###xml 442 458 <span type="species:ncbi:272563">C. difficile 630</span>
###xml 787 808 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Regulatory genes form a large proportion of the 027-specific genes, with 8 two-component regulators and 15 other transcriptional regulators. One of the most striking regions of genetic difference was an additional complete copy of the agr regulatory locus (termed agr2), consisting of agrA (CDR20291_3189/CD196_3143), agrB (CDR20291_3187/CD196_3141), agrC (CDR20291_3188/CD196_3142) and agrD (CDR20291_3187a/CD196_3141a). The agr1 locus from C. difficile 630 contains only single copies of agrB and agrD, with the response regulator (agrA) and histidine protein kinase (agrC) genes absent. The agr1 locus was present in both 027 strains. The complete agr locus (agrA to agrD) has been identified as a key regulatory system involved in multiple aspects of virulence and quorum sensing in Staphylococcus aureus [54]. Downstream of the agr2 locus are three 027-specific CDSs that encode two putative membrane proteins and an ABC transporter ATP-binding protein.
###end p 45
###begin p 46
###xml 604 605 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 644 657 644 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 838 839 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 644 656 <span type="species:ncbi:1496">C. difficile</span>
One of the additional transcriptional regulators in the 027 ribotypes is a PadR-like transcriptional regulator (CDR20291_2964/CD196_2917). The PadR family regulates phenolic acid metabolism, which may be important in survival of bacteria in the gut, where energy sources are limited. The CDS is found within a region of six 027-specific genes - transcribed on the opposite strand to the other five CDSs - that encode a predicted enoate reductase, a nitrate/nitrite transporter and a conjugative transposon site-specific recombinase. The PadR regulator may also be important in tolerance or production of p-cresol, a phenolyic agent produced by C. difficile from the degradation of tyrosine. The p-cresol operon CD0153-155 was conserved within both 027s and in 630. However, there are clear phenotypic differences between the tolerance to p-cresol between the recent 027 isolates and 630 [55], which may be due to PadR or another transcriptional regulator.
###end p 46
###begin title 47
Genetic differences between the historic CD196 strain and the R20291 hypervirulent strain
###end title 47
###begin p 48
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 447 450 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">027</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 902 904 898 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">24</sup>
###xml 1048 1050 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1151 1153 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1319 1321 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
Sequence data show that there are at least five genetic regions unique to the epidemic 027 (R20291) compared to the non-epidemic 027 strain (CD196) (Table 3). We hypothesize that these newly identified R20291 genetic elements contribute to the virulent phenotype of this clone. These genetic regions include a unique approximately 20-kb phage island of high G+C DNA content termed SMPI1 inserted into a 027 unique conjugative transposon (named CTn027; Figure 6). This phage island insertion sequence disrupts the R20291 CDS CDR20291_1744 and carries a number of cargo genes present only in R20291, including a two-component response regulator (CDR20291_1748), a putative lantibiotic ABC transporter (CDR20291_1752), a putative cell surface protein along with a number of hypothetical and conserved hypothetical proteins. CDR20291_1755 is a unique R20291 gene encoding a transcriptional regulator (sigma24). The phage island also encodes a toxin-antitoxin system (RelE/StbE family) that is important in maintaining the stability of mobile elements [56]. RelE encodes a stable toxin that inhibits translation by cleaving mRNAs on translating ribosomes [57]. The toxin is inhibited by an unstable anti-toxin (RelB). This toxin-antitoxin system has been linked to translation moderation under amino-acid starvation stress [58].
###end p 48
###begin p 49
###xml 72 85 72 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of phage island SMPI (Stoke Mandeville phage island) between <italic>C. difficile </italic>strains 630, CD196 and R20291</bold>
###xml 72 84 <span type="species:ncbi:1496">C. difficile</span>
Comparison of phage island SMPI (Stoke Mandeville phage island) between C. difficile strains 630, CD196 and R20291.
###end p 49
###begin p 50
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">matE </italic>
Both 027 strains share a similar prophage (prophage phi-027), which has integrated between the orthologues of 630 CDSs CD1566-7. These prophages (CDR20291_1415-1465, CD196_1438-89) are identical apart from one small region. CD196 contains three strain-specific adjacent CDSs, the only CD196-specific CDS in the whole genome, which encode a putative phage anti-repressor and two putative uncharacterized proteins. R20291 appears to have lost these three CDSs and replaced them with a single putative uncharacterized protein that has 88% identity at the 5' end to one of the lost uncharacterized proteins and may represent a pseudogene. In addition, there is a unique R20291 region encoding six genes, including matE (CDR20291_1779), a member of the Multi-antimicrobial extrusion family drug/sodium antiporters. This region also shows a high G+C content, indicating recent acquisition.
###end p 50
###begin title 51
Acquisition of R20291-specific genes in other PCR-ribotype 027 strains over time
###end title 51
###begin p 52
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
In order to validate the presence of the R20291-specific genes and to monitor their acquisition over time, PCR analysis was undertaken on 19 PCR-ribotype 027 strains that have been isolated over a 16-year period across the US (Table 1). These isolates were typed by restriction endonuclease analysis as BI, which is equivalent to PCR-ribotype 027; however, each isolate represents a unique small variation found in the BI restriction endonuclease analysis patterns. Strains BI-1 to -5 are considered 'historic' and were isolated between 1988 and 1995. BI-6 to -17 are considered 'modern' and were isolated from 2001 to 2004. Strains 630 and CD196 (ribotypes 012 and 027, respectively) were used as negative controls (Table 4).
###end p 52
###begin p 53
Presence of R20291 specific genes in a time course of 19 PCR ribotype 027 strains designated BI-1 to -17
###end p 53
###begin p 54
###xml 61 74 61 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 61 77 <span type="species:ncbi:272563">C. difficile 630</span>
*Phage island. X = PCR positive, blank = PCR negative. 630 = C. difficile 630 sequence strain, SM = R20291 (epidemic 027), CD196 = original, non-epidemic 027, BI-1 to -5 = 'historic' ribotype 027 strains, BI-6 to -17 = 'modern' ribotype 027 strains.
###end p 54
###begin p 55
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Eleven R20291-specific genes were chosen for PCR analysis (Table 4). Four genes (CDR20291_1744, CDR20291_1751 to _1753) are found on the R20291-specific phage island; gene CDR20291_1744 is a site specific recombinase, CDR20291_1751 and CDR20291_1752 are putative lantibiotic ABC transporters and CDR20291_1753 is unknown. In addition, the R20291-specific transcriptional regulator (YobD protein) is also present in the 'modern' BI strains (6p, 8, 12, 16 and 17) but absent from the earlier BI strains. Only one R20291-specific gene (CDR20291_1419; BRO protein family) was amplified in the early BI strains (BI-1, -2 and -5), showing the acquisition of R20291 genes was more prevalent in the epidemic 027 BI strains (Table 4). Furthermore, recent data demonstrate that the epidemic 027 strain, named BI-6, is more virulent in the hamster infection model than early strains such as BI-1 [13].
###end p 55
###begin title 56
Conclusions
###end title 56
###begin p 57
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 758 766 758 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 0 12 <span type="species:ncbi:1496">C. difficile</span>
C. difficile is the most frequent cause of nosocomial diarrhea worldwide, in part due to the rapid and dramatic worldwide emergence of the PCR-ribotype 027 strains. We show that 027 strains have considerable genetic differences compared to strain 630 that may relate to observed phenotypic differences in motility, survival, antibiotic resistance and toxicity. Additionally, five genetic regions appear to have accumulated in the modern day epidemic 027 strain R20291 compared to the historic CD196 counterpart. This includes a unique approximately 20-kb phage island of high G+C content DNA (SMPI1) inserted into a 027 unique conjugative transposon. However, the role of individual determinants through mutagenesis and the testing of mutants in appropriate in vivo models is required to provide conclusive evidence. Some of these elements appear to have accumulated in 027 strains over the past 16 years and may therefore be useful genetic markers for epidemic 027 strains. The observed gene differences between these strains might individually or collectively explain why modern 027 strains are more likely to be epidemic and could explain the higher case-fatality ratio and persistence associated with infection by these strains. These studies facilitate pinpointing the genetic and phenotypic attributes that may explain the emergence of the hypervirulent 027 strain and contribute in general to our understanding of the evolution of bacterial virulence.
###end p 57
###begin title 58
Materials and methods
###end title 58
###begin title 59
Bacterial strains and growth conditions
###end title 59
###begin p 60
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 116 129 116 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 0 12 <span type="species:ncbi:1496">C. difficile</span>
###xml 116 132 <span type="species:ncbi:272563">C. difficile 630</span>
###xml 158 165 <span type="species:ncbi:9606">patient</span>
###xml 407 414 <span type="species:ncbi:9606">patient</span>
C. difficile 027 isolates designated BI-1 to -17 were provided by Dale Gerding (Hines VA Hospital, Hines, IL, USA). C. difficile 630 [59] was isolated from a patient with PMC in Zurich, 1982 and has been fully sequenced by the Wellcome Trust Sanger Institute [22]. Strain 630 was provided by Peter Mullany, Eastman Dental Institute, London, UK. The 027 strain CD196 is a non-epidemic strain isolated from a patient with PMC in Paris, 1985 and was provided by Michel Popoff, Institut Pasteur, Paris, France. The hypervirulent 027 R20291 was isolated from a recent outbreak in Stoke Mandeville, UK and was provided by Jon Brazier, Anaerobe Reference Laboratory, Cardiff, UK.
###end p 60
###begin p 61
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 122 135 122 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 245 258 245 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 399 400 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 12 <span type="species:ncbi:1496">C. difficile</span>
###xml 122 134 <span type="species:ncbi:1496">C. difficile</span>
###xml 183 188 <span type="species:ncbi:9796">horse</span>
###xml 245 257 <span type="species:ncbi:1496">C. difficile</span>
C. difficile was routinely cultured on Braziers agar (Bioconnections, Leeds, South Yorkshire, UK) containing 4% egg yolk, C. difficile supplement (Bioconnections) and 2% defibrinated horse blood or in brain heart infusion (BHI) broth containing C. difficile supplement (Oxoid, Basingstoke, Hampshire, UK) and 0.04% cysteine. All cultures were grown in an anaerobic atmosphere (10% CO2, 10% H2, 80% N2) at 37degreesC.
###end p 61
###begin title 62
DNA isolation and PCR amplification
###end title 62
###begin p 63
###xml 8 21 8 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 8 20 <span type="species:ncbi:1496">C. difficile</span>
Genomic C. difficile DNA was isolated by cell lysis, phenol chloroform extraction and ethanol precipitation. Briefly, overnight cultures were resuspended in 3 ml EDTA and incubated at 37degreesC for 1 hour with 20 mg/ml lysozyme (Sigma-Aldrich, Gillingham, Dorset, UK), 10 KU/ml mutanolysin (Sigma-Aldrich), 5 mg/ml lysostaphin (Sigma-Aldrich) and 100 mg/ml RNase (Invitrogen, Paisley, Renfrewshire, UK). Proteinase K (25 mg/ml; Sigma-Aldrich) and 20% SDS (Sigma-Aldrich) were added to the cell suspension and incubated at 50degreesC for 1 hour. DNA was extracted by phenol:chloroform:IAA (Sigma-Aldrich) washes and chloroform:IAA (Sigma-Aldrich) washes. Genomic DNA was precipitated using 100% ethanol and purified with two washes of 80% ethanol. Purity was assessed and quantification done using a NanoDrop1000 spectrophotometer and by running the samples on 1.0% agarose gel, 100 mV for 45 minutes.
###end p 63
###begin p 64
PCR amplifications were performed using primers described in Additional data file 3. Reactions were performed using 35 cycles at 94degreesC for 15 seconds, 50degreesC for 1 minute, 72degreesC for 1 minute, followed by a final extension of 72degreesC for 7 minutes. PCR products were analyzed on 1% agarose gels run at 100 mV for 1 hour and stained with ethidium bromide.
###end p 64
###begin title 65
DNA sequencing and assembly
###end title 65
###begin p 66
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 842 850 842 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1474 1475 1474 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
Genomic sequences were generated by combining data from 454/Roche technology (using GS20 for R20291 and FLX for CD196) with shotgun capillary reads from ABI 3730xl analyzers (Table 5). Reads from the 454 platform were assembled de novo (without guidance from a reference sequence) into contigs using newbler (Roche, Welwyn Garden City, Hertfordshire, UK), then shredded into artificial reads of comparable lengths to capillary reads. An assembly was created with data from both platforms using Phrap. For each combined assembly the order of contigs was estimated by comparing them to strain 630 genomic sequence using ABACAS [60]. To further correct homopolymer tract errors inherent in early 454 sequencing data, Solexa (Illumina, Saffron Walden, Essex) sequence data were generated for isolate R20291. The Illumina sequences were assembled de novo using Velvet [61] and the resulting contigs were incorporated with the combined 454 and capillary assembly. Closing gaps between contigs for both CD196 and R20291 was either by primer walking on subclones from the capillary shotgun or by sequencing PCR products covering gaps between adjacent contigs. The final contiguous sequence for CD196 was mostly from combined data but small regions were covered with only 454 data (a total of less than 2.6% of the sequence) or with only capillary reads, giving a consensus confidence of < 41 (< 0.3% of the sequence), and rRNA repeats were represented as consensus sequences (Table 5). All regions of the final finished R20291 assembly are covered by high quality capillary reads or by combinations of data from at least two sequencing technologies, although three gaps remain where ribosomal rRNA operons have not been bridged by read-pairs. All regions of the final finished R20291 assembly are covered by high quality capillary reads or by combinations of data from at least two sequencing technologies.
###end p 66
###begin p 67
Average sequence coverage from aligned reads
###end p 67
###begin title 68
Genome annotation, comparison and orthologue identification
###end title 68
###begin p 69
###xml 21 34 21 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 108 121 108 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 21 33 <span type="species:ncbi:1496">C. difficile</span>
###xml 108 120 <span type="species:ncbi:1496">C. difficile</span>
Genome annotation of C. difficile strains CD196 and R20291 was based on previously published annotations of C. difficile strain 630 [22]. The genomic sequences of strains CD196 and R20291 were compared against the database of strain 630 proteins by blastx, and a CDS feature in the query genome was created when a hit of over 90% identity was found. Glimmer3 [62] was used to predict CDSs in genomic regions where no significant hits were found. Any unique genomic regions left were examined and annotated manually in Artemis [63]. The genome comparisons were visualized in Artemis and ACT (Artemis Comparison Tool) [64]. The sequences of CD196 and R20291 can be accessed using the accession numbers [EMBL: ] and [EMBL: ], respectively.
###end p 69
###begin p 70
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
The reciprocal-best-hit fasta search algorithm was used to identify orthologues among strains 630, CD196 and R20291. All CDSs in the query genome were searched in the database of subject CDSs by FASTA [65]. When a hit of over 30% identity and over 80% length was found, the hit CDS in the subject genome was searched again in the database of query CDSs in a similar fashion. If the hit of the second search is the same as the original query CDS, the two CDSs are considered as orthologues by this method. These identified orthologues were manually curated to account for inaccuracies caused by inserted elements, frameshifts and pseudogenes.
###end p 70
###begin title 71
Toxin B toxicity assay
###end title 71
###begin p 72
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 227 229 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
Toxins were produced by the dialyzing cultivation method [66] with BHI broth (Oxoid) as outer medium and 10% NaCl as inner medium. Cultures were performed at 37degreesC for 4 days. Toxin B was purified as previously described [67] using ion exchange chromatography (DEAE-Sephacel, GE Healthcare Life Sciences, Little Chalfont, Buckinghamshire UK) and gel filtration (Superdex G200, GE Healthcare Life Sciences). Toxin B preparations were analyzed by SDS-PAGE and the band corresponding to toxin B for each strain was quantified by gel densitometry (Additional data file 4).
###end p 72
###begin p 73
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
Cytotoxicity assays were performed as previously described [68]. Subconfluent cell monolayers were obtained in 96 well plates and were inoculated with serial dilutions of toxin B samples. The cells were monitored for 24 hours after inoculation for morphological alteration. The cytotoxicity titer corresponds to the reciprocal of the greater dilution giving rounding up in 50% of the cells and is expressed as toxin molarity (corresponding to toxin specific activity).
###end p 73
###begin title 74
Motility assay
###end title 74
###begin p 75
Cultures were grown anaerobically for 1 to 2 days on Braziers media from glycerol stocks. BHI agar (0.05%) was poured into 30 ml glass vials that were then pre-equilibrated for 4 hours in the anaerobe chamber. Three single colonies were picked with a loop and inoculated into the top 2 to 5 mm of BHI agar in the glass vial. These were then left overnight in the anaerobe chamber; the vials were then removed from the anaerobe chamber and photographed to record the motility.
###end p 75
###begin title 76
Minimum inhibitory concentration determination using Etest
###end title 76
###begin p 77
###xml 189 202 189 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 310 323 310 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 425 426 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 433 434 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 441 442 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 189 201 <span type="species:ncbi:1496">C. difficile</span>
###xml 286 291 <span type="species:ncbi:9796">horse</span>
###xml 310 322 <span type="species:ncbi:1496">C. difficile</span>
Chloramphenicol, erythromycin, tetracycline and fluoroquinolones (gatifloxacin, mocifloxacin and lexofloxacin) MICs were determined using Etest strips (Biomerieux, Marcy l'Etoile, France). C. difficile was cultured overnight on Brazier's CCEY agar (Bioconnections) with 1% defibrinated horse blood (Oxoid) and C. difficile supplement (Bioconnections). All cultures were undertaken at 37degreesC in an anaerobe chamber (10% CO2, 10% H2, 80% N2). A bacterial suspension in BHI (no. 3 McFarland standard) was inoculated onto the surface of Brazier's agar and was then dried for 15 to 30 minutes. Etest strips were placed onto agar surface. Agar plates were incubated anaerobically (37degreesC) for 24 hours and 48 hours, and MICs were determined following the manufacturer's instructions.
###end p 77
###begin title 78
Statistical analysis
###end title 78
###begin p 79
###xml 73 86 73 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 73 89 <span type="species:ncbi:272563">C. difficile 630</span>
Chloramphenicol, erythromycin, tetracycline and fluoroquinolone MICs for C. difficile 630, CD196 and R20291 were analyzed by Tukey test using GraphPad Prism 4 software (La Jolla, CA, USA). P-value < 0.05 was considered statistically significant.
###end p 79
###begin title 80
Abbreviations
###end title 80
###begin p 81
###xml 32 45 32 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 32 44 <span type="species:ncbi:1496">C. difficile</span>
BHI: brain heart infusion; CDI: C. difficile infection; CDS: coding sequence; IS: Insertion Sequence; MIC: minimum inhibitory concentration; PaLoc: pathogenicity locus; PMC: pseudomembranous colitis; SMPI: Stoke Mandeville phage island.
###end p 81
###begin title 82
Authors' contributions
###end title 82
###begin p 83
RAS, JP, GD and BWW conceived of the study. MAQ and GR performed the sequencing experiments. MH, CC, MS, TDL and JP performed the data analysis. MG and MRP performed toxin B toxicity assays, LD performed motility and autoagglutination assays, EV performed MIC assays, MM performed PCR analysis, and DNG provided strains and critical analysis. RAS, LD, JP, MH and BWW drafted the manuscript. All authors contributed to and approved the final manuscript.
###end p 83
###begin title 84
Additional data files
###end title 84
###begin p 85
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
The following additional data are available with the online version of this paper: CDSs specific to PCR-ribotype 027 isolates (Additional data file 1); CDSs that have been disrupted by an insertion in both 027 strains but are intact in 630, and CDSs that are intact in both 027 strains but have been disrupted in 630 (Additional data file 2); R20291-specific gene primers used in this study (Additional data file 3); SDS-PAGE of toxin B preparations (Additional data file 4).
###end p 85
###begin title 86
Supplementary Material
###end title 86
###begin title 87
Additional data file 1
###end title 87
###begin p 88
CDS specific to PCR-ribotype 027 isolates.
###end p 88
###begin p 89
Click here for file
###end p 89
###begin title 90
Additional data file 2
###end title 90
###begin p 91
Fourteen CDSs have been disrupted by an insertion in both 027 strains but are intact in 630, and, conversely, 12 CDSs are intact in both 027 strains but have been disrupted in 630.
###end p 91
###begin p 92
Click here for file
###end p 92
###begin title 93
Additional data file 3
###end title 93
###begin p 94
R20291-specific gene primers used in this study.
###end p 94
###begin p 95
Click here for file
###end p 95
###begin title 96
Additional data file 4
###end title 96
###begin p 97
Toxin B was quantified by gel densitometry. 1 = VPI10463, 2 = CD196, 3 = 630.
###end p 97
###begin p 98
Click here for file
###end p 98
###begin title 99
Acknowledgements
###end title 99
###begin p 100
We thank Jon Brazier for provision of strain R20291 and Frances Smith for assistance with library making. We acknowledge the Wellcome Trust for funding this research.
###end p 100
###begin article-title 101
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 64 77 64 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 38 59 <span type="species:ncbi:1496">Clostridium difficile</span>
###xml 64 76 <span type="species:ncbi:1496">C. difficile</span>
Historical perspectives on studies of Clostridium difficile and C. difficile infection.
###end article-title 101
###begin article-title 102
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism.
###end article-title 102
###begin article-title 103
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
Clostridium difficile: changing epidemiology and new treatment options.
###end article-title 103
###begin article-title 104
###xml 27 49 27 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 27 48 <span type="species:ncbi:1496">Clostridium difficile</span>
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.
###end article-title 104
###begin article-title 105
###xml 50 72 50 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 138 150 138 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile</italic>
###xml 50 71 <span type="species:ncbi:1496">Clostridium difficile</span>
###xml 138 150 <span type="species:ncbi:1496">C. difficile</span>
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec.
###end article-title 105
###begin article-title 106
###xml 55 76 55 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 55 76 <span type="species:ncbi:1496">Clostridium difficile</span>
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
###end article-title 106
###begin article-title 107
###xml 47 60 47 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile </italic>
###xml 20 24 <span type="species:ncbi:1280">MRSA</span>
###xml 47 59 <span type="species:ncbi:1496">C. difficile</span>
Annual incidence of MRSA falls in England, but C. difficile continues to rise.
###end article-title 107
###begin article-title 108
###xml 12 33 12 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 12 33 <span type="species:ncbi:1496">Clostridium difficile</span>
Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.
###end article-title 108
###begin article-title 109
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 22 43 <span type="species:ncbi:1496">Clostridium difficile</span>
Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.
###end article-title 109
###begin article-title 110
###xml 32 54 32 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 32 53 <span type="species:ncbi:1496">Clostridium difficile</span>
Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust
###end article-title 110
###begin article-title 111
###xml 76 97 76 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 76 97 <span type="species:ncbi:1496">Clostridium difficile</span>
Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.
###end article-title 111
###begin article-title 112
###xml 52 74 52 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 52 73 <span type="species:ncbi:1496">Clostridium difficile</span>
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.
###end article-title 112
###begin article-title 113
###xml 63 84 63 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 63 84 <span type="species:ncbi:1496">Clostridium difficile</span>
Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
###end article-title 113
###begin article-title 114
###xml 29 51 29 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 29 50 <span type="species:ncbi:1496">Clostridium difficile</span>
Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.
###end article-title 114
###begin article-title 115
###xml 25 47 25 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 25 46 <span type="species:ncbi:1496">Clostridium difficile</span>
The toxigenic element of Clostridium difficile strain VPI 10463.
###end article-title 115
###begin article-title 116
###xml 38 59 38 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 38 59 <span type="species:ncbi:1496">Clostridium difficile</span>
Toxin B is essential for virulence of Clostridium difficile.
###end article-title 116
###begin article-title 117
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
###end article-title 117
###begin article-title 118
###xml 42 64 42 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 42 63 <span type="species:ncbi:1496">Clostridium difficile</span>
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
###end article-title 118
###begin article-title 119
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
Clostridium difficile toxin synthesis is negatively regulated by TcdC.
###end article-title 119
###begin article-title 120
###xml 131 153 131 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 131 152 <span type="species:ncbi:1496">Clostridium difficile</span>
Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
###end article-title 120
###begin article-title 121
###xml 39 61 39 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 39 60 <span type="species:ncbi:1496">Clostridium difficile</span>
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
###end article-title 121
###begin article-title 122
###xml 39 61 39 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 39 60 <span type="species:ncbi:1496">Clostridium difficile</span>
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.
###end article-title 122
###begin article-title 123
###xml 78 100 78 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 78 99 <span type="species:ncbi:1496">Clostridium difficile</span>
A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.
###end article-title 123
###begin article-title 124
###xml 64 85 64 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 64 85 <span type="species:ncbi:1496">Clostridium difficile</span>
Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.
###end article-title 124
###begin article-title 125
###xml 62 84 62 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 62 83 <span type="species:ncbi:1496">Clostridium difficile</span>
New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia.
###end article-title 125
###begin article-title 126
Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
###end article-title 126
###begin article-title 127
###xml 20 42 20 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 20 41 <span type="species:ncbi:1496">Clostridium difficile</span>
Toxigenic status of Clostridium difficile in a large Spanish teaching hospital.
###end article-title 127
###begin article-title 128
###xml 95 116 95 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 95 116 <span type="species:ncbi:1496">Clostridium difficile</span>
Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.
###end article-title 128
###begin article-title 129
###xml 54 76 54 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 112 124 112 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. difficile</italic>
###xml 54 75 <span type="species:ncbi:1496">Clostridium difficile</span>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 112 124 <span type="species:ncbi:1496">C. difficile</span>
Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland.
###end article-title 129
###begin article-title 130
###xml 81 102 81 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 81 102 <span type="species:ncbi:1496">Clostridium difficile</span>
Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.
###end article-title 130
###begin article-title 131
###xml 16 38 16 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 16 37 <span type="species:ncbi:1496">Clostridium difficile</span>
Distribution of Clostridium difficile PCR ribotype 027 in British hospitals.
###end article-title 131
###begin article-title 132
###xml 21 42 21 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 21 42 <span type="species:ncbi:1496">Clostridium difficile</span>
Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.
###end article-title 132
###begin article-title 133
###xml 21 42 21 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 21 42 <span type="species:ncbi:1496">Clostridium difficile</span>
Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
###end article-title 133
###begin article-title 134
###xml 23 45 23 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 23 44 <span type="species:ncbi:1496">Clostridium difficile</span>
A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.
###end article-title 134
###begin article-title 135
###xml 27 49 27 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 27 48 <span type="species:ncbi:1496">Clostridium difficile</span>
Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator.
###end article-title 135
###begin article-title 136
###xml 44 66 44 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 44 65 <span type="species:ncbi:1496">Clostridium difficile</span>
gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.
###end article-title 136
###begin article-title 137
###xml 18 39 18 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 18 39 <span type="species:ncbi:1496">Clostridium difficile</span>
Ciprofloxacin and Clostridium difficile-associated diarrhoea.
###end article-title 137
###begin article-title 138
###xml 24 45 24 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 24 45 <span type="species:ncbi:1496">Clostridium difficile</span>
Fluoroquinolone use and Clostridium difficile-associated diarrhea.
###end article-title 138
###begin article-title 139
###xml 20 41 20 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 20 41 <span type="species:ncbi:1496">Clostridium difficile</span>
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.
###end article-title 139
###begin article-title 140
###xml 90 111 90 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 90 111 <span type="species:ncbi:1496">Clostridium difficile</span>
Fluoroquinolone use is the predominant risk factor for the development of a new strain of Clostridium difficile-associated disease.
###end article-title 140
###begin article-title 141
###xml 27 52 27 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpulina hyodysenteriae </italic>
###xml 27 51 <span type="species:ncbi:159">Serpulina hyodysenteriae</span>
###xml 112 118 <span type="species:ncbi:10090">murine</span>
###xml 128 133 <span type="species:ncbi:9823">swine</span>
Dual flaA1 flaB1 mutant of Serpulina hyodysenteriae expressing periplasmic flagella is severely attenuated in a murine model of swine dysentery.
###end article-title 141
###begin article-title 142
###xml 60 80 60 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica </italic>
###xml 60 79 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 104 109 <span type="species:ncbi:9031">chick</span>
The role of flagella, but not fimbriae, in the adherence of Salmonella enterica serotype Enteritidis to chick gut explant.
###end article-title 142
###begin article-title 143
###xml 20 36 20 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae </italic>
###xml 62 71 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 20 38 <span type="species:ncbi:127906">Vibrio cholerae O1</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Motility mutants of Vibrio cholerae O1 have reduced adherence in vitro to human small intestinal epithelial cells as demonstrated by ELISA.
###end article-title 143
###begin article-title 144
###xml 32 54 32 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 32 53 <span type="species:ncbi:1496">Clostridium difficile</span>
Characterization of flagella of Clostridium difficile and their role in serogrouping reactions.
###end article-title 144
###begin article-title 145
###xml 70 92 70 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 70 91 <span type="species:ncbi:1496">Clostridium difficile</span>
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups.
###end article-title 145
###begin article-title 146
Flagellar glycosylation - a new component of the motility repertoire?
###end article-title 146
###begin article-title 147
###xml 109 130 109 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas syringae </italic>
###xml 109 140 <span type="species:ncbi:322">Pseudomonas syringae pv. tabaci</span>
A homologue of the 3-oxoacyl-(acyl carrier protein) synthase III gene located in the glycosylation island of Pseudomonas syringae pv. tabaci regulates virulence factors via N-acyl homoserine lactone and fatty acid synthesis.
###end article-title 147
###begin article-title 148
###xml 42 56 42 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Campylobacter </italic>
Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence.
###end article-title 148
###begin article-title 149
###xml 2 23 2 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Campylobacter jejuni </italic>
###xml 2 22 <span type="species:ncbi:197">Campylobacter jejuni</span>
###xml 121 129 <span type="species:ncbi:9031">chickens</span>
A Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis and colonisation of chickens.
###end article-title 149
###begin article-title 150
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 0 21 <span type="species:ncbi:1496">Clostridium difficile</span>
Clostridium difficile
###end article-title 150
###begin article-title 151
RmlC, a C3' and C5' carbohydrate epimerase, appears to operate via an intermediate with an unusual twist boat conformation.
###end article-title 151
###begin article-title 152
###xml 62 82 62 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus mutans</italic>
###xml 62 82 <span type="species:ncbi:1309">Streptococcus mutans</span>
Biological function of the dTDP-rhamnose synthesis pathway in Streptococcus mutans.
###end article-title 152
###begin article-title 153
###xml 110 131 110 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus mutans </italic>
###xml 110 130 <span type="species:ncbi:1309">Streptococcus mutans</span>
Recombination between gtfB and gtfC is required for survival of a dTDP-rhamnose synthesis-deficient mutant of Streptococcus mutans in the presence of sucrose.
###end article-title 153
###begin article-title 154
Autoinduction and signal transduction in the regulation of staphylococcal virulence.
###end article-title 154
###begin article-title 155
###xml 44 65 44 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 44 65 <span type="species:ncbi:1496">Clostridium difficile</span>
Assessing the role of p-cresol tolerance in Clostridium difficile.
###end article-title 155
###begin article-title 156
A family of stability determinants in pathogenic bacteria.
###end article-title 156
###begin article-title 157
RelE toxins from bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA.
###end article-title 157
###begin article-title 158
RelE, a global inhibitor of translation, is activated during nutritional stress.
###end article-title 158
###begin article-title 159
###xml 74 95 74 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 74 95 <span type="species:ncbi:1496">Clostridium difficile</span>
Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile.
###end article-title 159
###begin article-title 160
ABACAS: algorithm-based automatic contiguation of assembled sequences.
###end article-title 160
###begin article-title 161
Velvet: algorithms for de novo short read assembly using de Bruijn graphs.
###end article-title 161
###begin article-title 162
Improved microbial gene identification with GLIMMER.
###end article-title 162
###begin article-title 163
Artemis: sequence visualization and annotation.
###end article-title 163
###begin article-title 164
ACT: the Artemis Comparison Tool.
###end article-title 164
###begin article-title 165
###xml 10 31 10 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile</italic>
###xml 10 31 <span type="species:ncbi:1496">Clostridium difficile</span>
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.
###end article-title 165
###begin article-title 166
###xml 32 54 32 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium botulinum </italic>
###xml 32 53 <span type="species:ncbi:1491">Clostridium botulinum</span>
Isolation and molecular size of Clostridium botulinum type C toxin.
###end article-title 166
###begin article-title 167
###xml 52 74 52 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 52 73 <span type="species:ncbi:1496">Clostridium difficile</span>
Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
###end article-title 167
###begin article-title 168
###xml 23 45 23 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium difficile </italic>
###xml 23 44 <span type="species:ncbi:1496">Clostridium difficile</span>
Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.
###end article-title 168

